Physician profile
Donald Thomas
NPI 1124454079
$100,155.97
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $100K · 2023: $17.84 · 2024: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $355.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $99,800.00 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $76.85 | 2024 | |
| Novo Nordisk INC | $74.84 | 2024 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $57.24 | 2024 | Airsupra |
| Dexcom, INC. | $25.12 | 2024 | Dexcom G6 Transmitter |
| Si-Bone, INC. | $23.07 | 2024 | |
| Abbvie INC. | $22.39 | 2024 | |
| Glaxosmithkline, LLC. | $22.27 | 2024 | Trelegy Ellipta |
| Abbott Laboratories | $20.44 | 2024 | Freestyle Libre 3 |
| Teva Pharmaceuticals USA, INC. | $17.84 | 2023 | Austedo Xr |
| Pfizer INC. | $15.91 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.